Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

April 16, 2024

https://www.globenewswire.com/news-release/2024/04/16/2864095/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html

BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq:ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on April 12, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.